期刊文献+

人STAT3基因siRNA真核表达质粒的构建及鉴定

Construction and identification of the eukaryotic vector expressing siRNA targeting human STAT3 gene
下载PDF
导出
摘要 目的:构建针对人STAT3基因的siRNA真核表达质粒,检测其在细胞水平对STAT3基因表达的抑制效果。方法:用DNA重组技术将针对人STAT3基因mRNA序列不同位点设计的3个siRNA序列克隆到真核表达质粒pRNAT-U6.1/neo中构建重组体pRNAT-U6.1-siRNA,重组质粒经PCR检测及测序分析,用脂质体转染重组质粒至人食管癌Eca-109细胞,G418筛选获得阳性克隆,RT-PCR和Western blot检测STAT3基因mRNA和蛋白的表达,筛选最佳沉默效率的siRNA。结果:PCR检测及测序分析结果均提示重组质粒构建正确。RT-PCR和Western blot检测证实pRNAT-U6.1-siRNA3具有最佳的沉默效率。结论:成功构建人STAT3基因siRNA真核表达质粒,并证实其能够从mRNA和蛋白水平抑制STAT3基因的表达。 Objective:To construct siRNA eukaryotic expression vector targeting of human STAT3 gene,and identify its suppressive effect.Methods:Three specific siRNAs targeting of human STAT3 gene were synthesized and cloned into eukaryotic expression plasmid pRNAT-U6.1/neo to reconstruct recombinant plasmid pRNAT-U6.1-siRNA-STAT3,which was then identified by PCR test and DNA sequence analysis.The recombinant plasmid was transfected into human esophageal carcinoma cell line Eca-109,the positive cell clones were screened with G418,the suppression effect of STAT3 mRNA and protein was measured by RT-PCR and Western blot to select the optimal siRNA.Results:PCR test and DNA sequence analysis showed that the recombinant plasmid was constructed successfully.RT-PCR and Western blot analyses demonstrated that the optimal siRNA which could effectively silence the target gene pRNAT-U6.1-siRNA3.Conclusion:The siRNA eukaryotic expression vector targeting of human STAT3 gene was constructed successfully,which could inhibit the expression of STAT3 gene.
出处 《临床肿瘤学杂志》 CAS 2009年第11期974-979,共6页 Chinese Clinical Oncology
关键词 STAT3 RNA干扰 食管癌细胞 STAT3 RNA interference Esophageal carcinoma cell
  • 相关文献

参考文献13

  • 1Buettner R, Mora LB, Jove R. Activated Stat signaling in human tumors provides novel molecular targets for therapeutic intervention [ J ]. Clin Cancer Res, 2002,8 (4) :945 - 954.
  • 2Bowman T, Garcia R, Turkson J, et al. Stats in oncogenesis [ J ]. Oncogene, 2000,19 ( 21 ) :2474 - 2488.
  • 3Trovato M, Vitarelli E, Grosso M, et al. Immunohistochemical expression of HGF, c-MET and transcription factor Stat3 in colorectal tumors [ J ]. Eur J Histochem, 2004,48 ( 3 ) :291 - 298.
  • 4Yu H, Jove R. The STATs of cancer: new molecular targets come of age[J]. Nat Ray Cancer, 2004,4(2) :97 - 105.
  • 5Liu N, Shimizu S, ho-Ihara T, et al. Angiotension Ⅱ receptor blockade ameliorates mesangio-proliferative glomerulonephritis in rats through suppression of CTGF and PA Ⅱ , independently of the coagulation system [ J]. Nephron Exp Nephrol, 2007,105 (3) :65 -74.
  • 6Aigner A. Nonviral in vivo delivery of therapeutic small interfering RNAs[J]. Curr Opin Mol Ther, 2007,9(2) :345 -352.
  • 7Akhtar S, Benter IF. Nonviral delivery of synthetic siRNAs in vivo[J]. JClinInvest, 2007,117(8) :3623 -3632.
  • 8TuschI IF, Meister G. Mechanisms of gene silencing by doubledstranded RNA [ J ]. Nature, 2004,431 ( 5014 ) :343 - 349.
  • 9Ahmed-Choudhury J, Williams KT, Young LS, et al. CD40 mediated human cholangiocyte apoptosis requires JAK-dependent activation of Star3 in addition to activation of JNK1/2 and ERK1/2 [J]. Cell Signal, 2006,18(4) :456 -468.
  • 10Hoey T, Grusby MJ. STATs as mediators of cytokine-induced response[ J ]. J Adv Immunol, 1998,71 : 145.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部